129 related articles for article (PubMed ID: 16314938)
1. Hypofractionated radiotherapy boost for dose escalation as a treatment option for high-grade spinal cord astrocytic tumor.
Katoh N; Shirato H; Aoyama H; Onimaru R; Suzuki K; Hida K; Miyasaka K; Iwasaki Y
J Neurooncol; 2006 May; 78(1):63-9. PubMed ID: 16314938
[TBL] [Abstract][Full Text] [Related]
2. The role of radiotherapy in the management of spinal cord glioma.
Shirato H; Kamada T; Hida K; Koyanagi I; Iwasaki Y; Miyasaka K; Abe H
Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):323-8. PubMed ID: 7673019
[TBL] [Abstract][Full Text] [Related]
3. Hypofractionated Stereotactic Radiotherapy as a Salvage Therapy for Recurrent High-Grade Gliomas: Single-Center Experience.
Reynaud T; Bertaut A; Farah W; Thibouw D; Crehange G; Truc G; Vulquin N
Technol Cancer Res Treat; 2018 Jan; 17():1533033818806498. PubMed ID: 30343637
[TBL] [Abstract][Full Text] [Related]
4. Radiotherapy of spinal cord gliomas : A retrospective mono-institutional analysis.
Corradini S; Hadi I; Hankel V; Ertl L; Ganswindt U; Belka C; Niyazi M
Strahlenther Onkol; 2016 Mar; 192(3):139-45. PubMed ID: 26519080
[TBL] [Abstract][Full Text] [Related]
5. Treatment outcomes of radiotherapy for primary spinal cord glioma.
Choi SH; Yoon HI; Yi S; Park JW; Cho J; Shin DA; Ha Y; Kim DS; Kim SH; Lee SK; Chang JH; Suh CO
Strahlenther Onkol; 2019 Feb; 195(2):164-174. PubMed ID: 30203111
[TBL] [Abstract][Full Text] [Related]
6. Hypofractionated external beam radiotherapy to boost the prostate with ≥85 Gy/equivalent dose for patients with localised disease at high risk of lymph node involvement: feasibility, tolerance and outcome.
Zilli T; Jorcano S; Escudé L; Linero D; Rouzaud M; Dubouloz A; Miralbell R
Clin Oncol (R Coll Radiol); 2014 Jun; 26(6):316-22. PubMed ID: 24667210
[TBL] [Abstract][Full Text] [Related]
7. Three-dimensional conformal radiotherapy for astrocytic tumors involving the eloquent area in children and young adults.
Nishihori T; Shirato H; Aoyama H; Onimaru R; Komae T; Ishii N; Ikeda J; Miyasaka K; Sawamura Y; Iwasaki Y
J Neurooncol; 2002 Nov; 60(2):177-83. PubMed ID: 12635666
[TBL] [Abstract][Full Text] [Related]
8. Dose-per-fraction escalation of accelerated hypofractionated three-dimensional conformal radiotherapy in locally advanced non-small cell lung cancer.
Kepka L; Tyc-Szczepaniak D; Bujko K
J Thorac Oncol; 2009 Jul; 4(7):853-61. PubMed ID: 19487965
[TBL] [Abstract][Full Text] [Related]
9. Radiotherapy in supratentorial gliomas. A study of 821 cases.
Heesters M; Molenaar W; Go GK
Strahlenther Onkol; 2003 Sep; 179(9):606-14. PubMed ID: 14628126
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of neurologic function in astrocytic spinal cord glioma.
Lee HK; Chang EL; Fuller GN; Aldape KD; Atkinson GJ; Levy LB; McCutcheon IE; Maor MH
Neuro Oncol; 2003 Jul; 5(3):208-13. PubMed ID: 12816727
[TBL] [Abstract][Full Text] [Related]
11. Pediatric low-grade and ependymal spinal cord tumors.
Merchant TE; Kiehna EN; Thompson SJ; Heideman R; Sanford RA; Kun LE
Pediatr Neurosurg; 2000 Jan; 32(1):30-6. PubMed ID: 10765136
[TBL] [Abstract][Full Text] [Related]
12. High-dose conformal radiotherapy for supratentorial malignant glioma: a historical comparison.
Tanaka M; Ino Y; Nakagawa K; Tago M; Todo T
Lancet Oncol; 2005 Dec; 6(12):953-60. PubMed ID: 16321763
[TBL] [Abstract][Full Text] [Related]
13. A retrospective analysis of 52 cases of spinal cord glioma managed with radiation therapy.
Rodrigues GB; Waldron JN; Wong CS; Laperriere NJ
Int J Radiat Oncol Biol Phys; 2000 Oct; 48(3):837-42. PubMed ID: 11020582
[TBL] [Abstract][Full Text] [Related]
14. Outcome after radiotherapy of primary spinal cord glial tumors.
McLaughlin MP; Buatti JM; Marcus RB; Maria BL; Mickle PJ; Kedar A
Radiat Oncol Investig; 1998; 6(6):276-80. PubMed ID: 9885944
[TBL] [Abstract][Full Text] [Related]
15. Hypofractionated boost to the dominant tumor region with intensity modulated stereotactic radiotherapy for prostate cancer: a sequential dose escalation pilot study.
Miralbell R; Mollà M; Rouzaud M; Hidalgo A; Toscas JI; Lozano J; Sanz S; Ares C; Jorcano S; Linero D; Escudé L
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):50-7. PubMed ID: 19910135
[TBL] [Abstract][Full Text] [Related]
16. Hypofractionated reirradiation for recurrent malignant glioma.
Henke G; Paulsen F; Steinbach JP; Ganswindt U; Isijanov H; Kortmann RD; Bamberg M; Belka C
Strahlenther Onkol; 2009 Feb; 185(2):113-9. PubMed ID: 19240998
[TBL] [Abstract][Full Text] [Related]
17. Accelerated hypofractionated adjuvant whole breast radiotherapy with concomitant photon boost after conserving surgery for early stage breast cancer: a prospective evaluation on 463 patients.
Cante D; Rosa La Porta M; Casanova-Borca V; Sciacero P; Girelli G; Pasquino M; Franco P; Ozzello F
Breast J; 2011; 17(6):586-93. PubMed ID: 21951485
[TBL] [Abstract][Full Text] [Related]
18. Long term results of a prospective dose escalation phase-II trial: interstitial pulsed-dose-rate brachytherapy as boost for intermediate- and high-risk prostate cancer.
Lettmaier S; Lotter M; Kreppner S; Strnad A; Fietkau R; Strnad V
Radiother Oncol; 2012 Aug; 104(2):181-6. PubMed ID: 22853851
[TBL] [Abstract][Full Text] [Related]
19. The results of hypofractionated radiotherapy in 31 patients with high-grade gliomas.
Sayin MY; Kaya B; Bakkal BH; Altundag K; Altundag MB
Med Oncol; 2007; 24(4):379-83. PubMed ID: 17917085
[TBL] [Abstract][Full Text] [Related]
20. Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study.
Shaw E; Arusell R; Scheithauer B; O'Fallon J; O'Neill B; Dinapoli R; Nelson D; Earle J; Jones C; Cascino T; Nichols D; Ivnik R; Hellman R; Curran W; Abrams R
J Clin Oncol; 2002 May; 20(9):2267-76. PubMed ID: 11980997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
